XML 56 R47.htm IDEA: XBRL DOCUMENT v3.23.3
REVENUE, CREDIT CONCENTRATIONS AND GEOGRAPHIC INFORMATION - Narrative (Details)
$ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2023
USD ($)
segment
Dec. 31, 2022
USD ($)
Concentration Risk And Geographic Information [Line Items]    
Number of operating business segment | segment 1  
Accounts receivable, net $ 572,498 $ 461,316 [1]
Sanofi    
Concentration Risk And Geographic Information [Line Items]    
Accounts receivable, net $ 54,800 $ 68,800
Credit Concentration Risk | Accounts Receivable | Customer One    
Concentration Risk And Geographic Information [Line Items]    
Concentration risk, percentage 16.00% 22.00%
Credit Concentration Risk | Accounts Receivable | Customer Two    
Concentration Risk And Geographic Information [Line Items]    
Concentration risk, percentage 11.00% 15.00%
[1] (1)December 31, 2022 balances were derived from the audited Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on February 27, 2023.